{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:52:43Z","timestamp":1781711563760,"version":"3.54.5"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Atypical fibroxanthoma (AFX) is an uncommon cutaneous neoplasm predominantly affecting elderly individuals in sun-exposed areas. Despite its alarming histopathological features, AFX typically exhibits an indolent clinical course. Diagnosis remains challenging due to overlapping features with other aggressive cutaneous malignancies, especially malignant melanoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We retrospectively analyzed 15 cases of AFX diagnosed between 2009 and 2024. Comprehensive immunohistochemical profiling was performed, including CD10, CD68, S100, Melan-A, HMB45, CD31, CD34, ERG, cytokeratins, P40, P63, SMA, Desmin, and newly, PRAME (clone EPR20330). Clinical and follow-up data were collected from medical records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The cohort had a mean age of 72.9 years, with a male predominance (66.7%). The scalp was the most frequent tumor site (40.0%). All cases demonstrated diffuse block-type CD10 positivity and were uniformly negative for PRAME. Occasional weak staining for melanocytic markers was observed in a minority of cases. After a mean follow-up of 84.0 months, all patients were alive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>A comprehensive immunohistochemical panel is essential for the accurate diagnosis of AFX. The absence of PRAME expression, together with block-type CD10 positivity, supports the distinction of AFX from malignant melanoma and other histological mimics, facilitating appropriate clinical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dad.0000000000003276","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:00:10Z","timestamp":1775599210000},"page":"509-514","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive Immunohistochemical Analysis of Atypical Fibroxanthoma: Focus on PRAME in Differential Diagnosis"],"prefix":"10.1097","volume":"48","author":[{"given":"Gozde","family":"Gungor Sahin","sequence":"first","affiliation":[{"name":"Department of Pathology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Eroglu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesimi","family":"Buyukbabani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey; and"},{"name":"Department of Pathology, Ko\u00e7 University, Faculty of Medicine, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0439-5954","authenticated-orcid":false,"given":"Sule","family":"Ozturk Sari","sequence":"additional","affiliation":[{"name":"Department of Pathology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"R1-20260617","doi-asserted-by":"crossref","first-page":"958","DOI":"10.5858\/arpa.2018-0112-RA","article-title":"Cutaneous spindle cell neoplasms: pattern-based diagnostic approach","volume":"142","author":"Choi","year":"2018","journal-title":"Arch Pathol Lab Med."},{"key":"R2-20260617","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/DAD.0b013e3181c80b97","article-title":"Atypical fibroxanthoma: a histological and immunohistochemical review of 171 cases","volume":"32","author":"Beer","year":"2010","journal-title":"Am J Dermatopathol."},{"key":"R4-20260617","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/j.semdp.2023.06.001","article-title":"The many faces of atypical fibroxanthoma","volume":"40","author":"Agaimy","year":"2023","journal-title":"Semin Diagn Pathol."},{"key":"R5-20260617","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5858\/arpa.2014-0495-RS","article-title":"Atypical fibroxanthoma","volume":"140","author":"L\u00f3pez","year":"2016","journal-title":"Arch Pathol Lab Med."},{"key":"R6-20260617","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/his.14797","article-title":"PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysis","volume":"81","author":"Hrycaj","year":"2022","journal-title":"Histopathology"},{"key":"R7-20260617","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0000000000001134","article-title":"PRAME expression in melanocytic tumors","volume":"42","author":"Lezcano","year":"2018","journal-title":"Am J Surg Pathol."},{"key":"R8-20260617","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-0560.2009.01425.x","article-title":"Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a review","volume":"37","author":"Luzar","year":"2010","journal-title":"J Cutan Pathol."},{"key":"R9-20260617","first-page":"5717","article-title":"Atypical fibroxanthoma - histological diagnosis, immunohistochemical markers and concepts of therapy","volume":"35","author":"Koch","year":"2015","journal-title":"Anticancer Res."},{"key":"R10-20260617","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/DAD.0000000000000313","article-title":"Spindle cell atypical fibroxanthoma: myofibroblastic differentiation represents a diagnostic pitfall in this variant of AFX","volume":"37","author":"Harding-Jackson","year":"2015","journal-title":"Am J Dermatopathol."},{"key":"R11-20260617","doi-asserted-by":"crossref","first-page":"105","DOI":"10.32074\/1591-951X-39-19","article-title":"Atypical fibroxanthoma\/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology","volume":"112","author":"Piras","year":"2020","journal-title":"Pathologica"},{"key":"R12-20260617","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/cup.12900","article-title":"Aberrant tyrosinase expression in an atypical fibroxanthoma: a case report","volume":"44","author":"Weiss","year":"2017","journal-title":"J Cutan Pathol."},{"key":"R13-20260617","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1600-0560.2006.00635.x","article-title":"Immunohistochemical staining of CD10 in atypical fibroxanthomas","volume":"34","author":"Hultgren","year":"2007","journal-title":"J Cutan Pathol."},{"key":"R14-20260617","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/modpathol.2011.173","article-title":"p40 (\u0394Np63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma","volume":"25","author":"Bishop","year":"2012","journal-title":"Mod Pathol."},{"key":"R15-20260617","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/PAS.0000000000000245","article-title":"p40 is more specific than p63 for the distinction of atypical fibroxanthoma from other cutaneous spindle cell malignancies","volume":"38","author":"Henderson","year":"2014","journal-title":"Am J Surg Pathol."},{"key":"R16-20260617","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/ijd.14705","article-title":"Leiomyosarcoma of the skin: review of the literature with an emphasis on prognosis and management","volume":"59","author":"Kazlouskaya","year":"2020","journal-title":"Int J Dermatol."},{"key":"R17-20260617","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1365-2559.2011.04070.x","article-title":"Dedifferentiated leiomyosarcoma: clinicopathological analysis of 18 cases","volume":"59","author":"Chen","year":"2011","journal-title":"Histopathology"},{"key":"R18-20260617","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.path.2017.01.007","article-title":"Atypical fibroxanthoma revisited","volume":"10","author":"Mentzel","year":"2017","journal-title":"Surg Pathol Clin."},{"key":"R19-20260617","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/cup.13787","article-title":"Atypical fibroxanthoma and pleomorphic dermal sarcoma: a reappraisal","volume":"48","author":"Cesinaro","year":"2021","journal-title":"J Cutan Pathol."},{"key":"R20-20260617","doi-asserted-by":"crossref","first-page":"e13962","DOI":"10.1111\/dth.13962","article-title":"Atypical fibroxanthoma: an analysis of 105 tumors","volume":"33","author":"Bitel","year":"2020","journal-title":"Dermatol Ther."},{"key":"R21-20260617","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1309\/AJCPRHM8CZH5EMFD","article-title":"The vascular marker CD31 also highlights histiocytes and histiocyte-like cells within cutaneous tumors","volume":"143","author":"Vanchinathan","year":"2015","journal-title":"Am J Clin Pathol."},{"key":"R22-20260617","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.anndiagpath.2010.07.012","article-title":"Cutaneous angiosarcoma. Analysis of 434 cases from the surveillance, epidemiology, and end results program, 1973-2007","volume":"15","author":"Albores-Saavedra","year":"2011","journal-title":"Ann Diagn Pathol."},{"key":"R23-20260617","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.anndiagpath.2013.08.004","article-title":"Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma","volume":"17","author":"Thum","year":"2013","journal-title":"Ann Diagn Pathol."},{"key":"R24-20260617","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/diagnostics12030646","article-title":"PRAME immunocytochemistry for the diagnosis of melanoma metastases in cytological samples","volume":"12","author":"Ronchi","year":"2022","journal-title":"Diagnostics"},{"key":"R25-20260617","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/DAD.0000000000002305","article-title":"Immunohistochemical characteristics of atypical fibroxanthoma and pleomorphic dermal sarcoma: a systematic review and meta-analysis","volume":"44","author":"\u00d8rholt","year":"2022","journal-title":"Am J Dermatopathol."},{"key":"R26-20260617","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/DAD.0b013e31815936ff","article-title":"Melanoma simulating atypical fibroxanthoma","volume":"29","author":"Sang\u00fceza","year":"2007","journal-title":"Am J Dermatopathol."},{"key":"R27-20260617","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.0303-6987.2004.00173.x","article-title":"HMB-45 (gp103) and MART-1 expression within giant cells in an atypical fibroxanthoma: a case report","volume":"31","author":"Smith-Zagone","year":"2004","journal-title":"J Cutan Pathol."},{"key":"R28-20260617","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/his.13139","article-title":"High prevalence of MiTF staining in undifferentiated pleomorphic sarcoma: caution in the use of melanocytic markers in sarcoma","volume":"70","author":"Choy","year":"2017","journal-title":"Histopathology"},{"key":"R29-20260617","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/cup.13346","article-title":"Immunohistochemical expression of melanocytic and myofibroblastic markers and their molecular correlation in atypical fibroxanthomas and pleomorphic dermal sarcomas","volume":"45","author":"Helbig","year":"2018","journal-title":"J Cutan Pathol."},{"key":"R30-20260617","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.path.2021.01.001","article-title":"PRAME immunohistochemistry as an ancillary test for the assessment of melanocytic lesions","volume":"14","author":"Lezcano","year":"2021","journal-title":"Surg Pathol Clin."},{"key":"R31-20260617","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3390\/diagnostics12092197","article-title":"PRAME immunoexpression in 275 cutaneous melanocytic lesions: a double institutional experience","volume":"12","author":"Cazzato","year":"2022","journal-title":"Diagnostics"},{"key":"R32-20260617","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/PAS.0000000000002125","article-title":"PRAME expression is a useful tool in the diagnosis of primary and metastatic dedifferentiated and undifferentiated melanoma","volume":"47","author":"Hornick","year":"2023","journal-title":"Am J Surg Pathol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:00:58Z","timestamp":1781708458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003276","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]}}}